Edges in Network
| Network | GSE11121_egf1520 - GSE11121 - SiGN-BN HC+Bootstrap |
| Network Description | The humoral immune system has a key prognostic impact in node-negative breast cancer |
| Node | SLC16A6 |
| Upstream (Parents) |
|---|
| (<<) CCND1 → SLC16A6 |
| (<<) CD4 → SLC16A6 |
| (<<) CDK7 → SLC16A6 |
| (<<) ELF5 → SLC16A6 |
| (<<) GDF15 → SLC16A6 |
| (<<) GLI3 → SLC16A6 |
| (<<) HDAC11 → SLC16A6 |
| (<<) HLA-F → SLC16A6 |
| (<<) MLPH → SLC16A6 |
| (<<) MMP7 → SLC16A6 |
| (<<) MSN → SLC16A6 |
| (<<) PHGDH → SLC16A6 |
| (<<) PLEKHF1 → SLC16A6 |
| (<<) PRKX → SLC16A6 |
| (<<) RBKS → SLC16A6 |
| (<<) RHOF → SLC16A6 |
| (<<) RHOG → SLC16A6 |
| (<<) SLC6A14 → SLC16A6 |
| (<<) SPDEF → SLC16A6 |
| (<<) TAF9 → SLC16A6 |
| (<<) TCF7L1 → SLC16A6 |
| (<<) TEX10 → SLC16A6 |
| (<<) UGDH → SLC16A6 |
| Downstream (Children) |
|---|
| SLC16A6 → BMP8B (>>) |
| SLC16A6 → CEBPD (>>) |
| SLC16A6 → EREG (>>) |
| SLC16A6 → GNE (>>) |
| SLC16A6 → HLA-A (>>) |
| SLC16A6 → HSPB1 (>>) |
| SLC16A6 → MAP3K12 (>>) |
| SLC16A6 → MMP10 (>>) |
| SLC16A6 → NFKBIE (>>) |
| SLC16A6 → RPS6KA5 (>>) |
| SLC16A6 → SULT4A1 (>>) |
| SLC16A6 → VPS37B (>>) |
